Small Molecules Capability

Australia is ideally positioned to be a major player in the global Pharma ecosystem where risk-averse companies are looking to in-licence assets that have demonstrated development potential.

Therefore, to enhance the progression of early stage discoveries through to preclinical development, TIA has formed a Small Molecules capability which is an integrated capability network of National Research Infrastructure across Australia. These facilities are committed to provide high quality research infrastructure to support leading‑edge research and to boost innovation in Australia.

 
Capabilities/Services offered  >

Compounds Australia

105_19_ACRF_COMBINATION_RGB_trimmed_sml.
 
TIA-Logo_Darker-Blue.jpg

Pipeline Accelerator

Support for screening projects
Capabilities/Services offered  >

Australian Translational Medicinal Chemistry Facility 

ATMCF.jpg
Capabilities/Services offered  >

Centre for Drug Candidate Optimisation

cdco.jpeg
 
Capabilities/Services offered  >

Centre for Integrated Preclinical Drug Development

Capabilities/Services offered  >

TetraQ

TetraQ logo_b.jpg
 

Contact us

+61 (07) 3735 4433

Subscribe to our newsletter to stay up-to-date on the latest news and events